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Abstract
Background: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is the
gold standard technique for mRNA quantification, but appropriate normalization is required to
obtain reliable data. Normalization to accurately quantitated RNA has been proposed as the most
reliable method for in vivo biopsies. However, this approach does not correct differences in RNA
integrity.
Results: In this study, we evaluated the effect of RNA degradation on the quantification of the
relative expression of nine genes (18S, ACTB, ATUB, B2M, GAPDH, HPRT, POLR2L, PSMB6 and RPLP0)
that cover a wide expression spectrum. Our results show that RNA degradation could introduce
up to 100% error in gene expression measurements when RT-qPCR data were normalized to total
RNA. To achieve greater resolution of small differences in transcript levels in degraded samples, we
improved this normalization method by developing a corrective algorithm that compensates for the
loss of RNA integrity. This approach allowed us to achieve higher accuracy, since the average error
for quantitative measurements was reduced to 8%. Finally, we applied our normalization strategy to
the quantification of EGFR, HER2 and HER3 in 104 rectal cancer biopsies. Taken together, our data
show that normalization of gene expression measurements by taking into account also RNA
degradation allows much more reliable sample comparison.
Conclusion: We developed a new normalization method of RT-qPCR data that compensates for
loss of RNA integrity and therefore allows accurate gene expression quantification in human
biopsies.
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Reverse transcription-quantitative polymerase chain
reaction (RT-qPCR) is the most sensitive method for
mRNA quantification [1-4] as it allows the detection of
rare transcripts and the observation of small variations in
gene expression. Quantification of mRNA by RT-qPCR
can be either absolute or relative. Absolute quantifica-
tion gives the precise copy number of a target mRNA, but
requires the construction of a calibration curve using
standards of known concentration. On the other hand,
relative quantification expresses the target quantity for
an experimental sample as an n-fold difference relative
to a calibrator. This is the method of choice to compare
changes in mRNA expression between different samples.
However, it requires data normalization in order to
obtain biologically relevant results [5]. Generally this
involves the use of one or several housekeeping genes,
whose expression is assumed to be stable between
individuals, experimental conditions or physiological
states.
In molecular oncology, pre-therapeutic biopsies are
interesting material for gene expression studies that
aim at identifying prognostic or predictive molecular
markers. However, it has been suggested that house-
keeping genes should not be used for normalization
when studies involve biopsies, since they exhibit large
expression variability between individuals [6]. As an
alternative, normalization to accurately quantitated total
RNA has been proposed [4] and then validated in breast
cancer biopsies [6]. This method relies on the precise
measurement of the template RNA concentration [6,7] in
order to ensure that equal amounts of RNA are used for
reverse transcription (RT). Nevertheless, this may not be
sufficient to allow reliable comparison among samples.
Indeed, variations in the template RNA quality can
introduce significant differences in subsequent RT-qPCR
results [8]. RNA quality encompasses both its purity
(absence of inhibitors) and its integrity (absence of
degradation). Variability is mostly related to RNA
integrity, as its degradation may greatly affect the
measured gene expression levels [8,9]. Besides, previous
studies suggested that there is a linear relation between
gene expression measurement and RNA degradation
[10-12]. However, to date, RNA integrity has not been
taken into account for normalization of gene expression
to total RNA.
The aim of this work was to evaluate the limits of
normalization to accurately quantitated total RNA when
using degraded samples and to improve this method by
introducing a normalization factor that compensates for
the loss of RNA integrity. For this purpose, using cell
lines we first assessed the influence of RNA degradation
on the quantification of the relative expression of nine
genes (18S, ACTB, ATUB, B2M, GAPDH, HPRT, POLR2L,
PSMB6 and RPLP0) that cover a wide expression
spectrum. Our results show that RNA degradation
could introduce large errors in gene expression measure-
ments when data were normalized to total RNA. There-
fore, to avoid unspecific variations due to RNA
degradation, we developed a corrective algorithm that
take into account the RNA integrity of each sample and
we validated the proposed model through the quantifi-
cation of EGFR, HER2 and HER3 mRNA in colon and
breast cancer cell lines. Finally, we applied this strategy
for the quantification of EGFR, HER2 and HER3 in rectal
cancer biopsies.
Results
Quality Control of the RT-qPCR assay
We accurately measured the RNA concentration of the
cell line samples using a tray cell system combined to a
SAFAS UV mc2 spectrophotometer, and we verified
sample purity by determining the A260/A280 ratio,
which was always comprised between 2.0 and 2.1.
To assess sample-to-sample variations in the efficiency of
both RT and PCR steps, we added a definite amount of
an exogenous plant mRNA control (CAB mRNA, Table 1)
to the RT reaction mix. After cDNA synthesis and
amplification by qPCR, CAB expression was detected
within a 1.5-fold range of concentration in all cell line
samples. This suggests that there was no significant
difference in the efficiency of both RT and PCR steps
between samples.
Effect of RNA degradation on relative gene expression
To evaluate the limits of normalization to total RNA
when using samples with impaired RNA integrity, we
studied the effect of RNA degradation on gene relative
expression. For that purpose, we aliquoted intact total
RNA from HCT116, BxPC-3 and A427 cell lines and we
gradually degraded each aliquot by hydrolysis at 70°C
for different length of time ranging between 0 and 165
min. We monitored the degree of degradation with an
Agilent 2100 bioanalyzer following the RNA integrity
number (RIN) classification [13]. For each cell line, we
obtained increasingly degraded samples, with RIN values
going from 10 to 4.7. Figure 1 illustrates this artificial
degradation by presenting the different degraded RNA
samples obtained for the HCT116 cell line. Subse-
quently, using the artificially degraded RNA samples,
we correlated the RIN of the input RNA with the relative
transcription level of 9 target genes (Table 1: Target
genes – training set), expressed as an n-fold difference
relative to the intact (RIN = 10) samples. For all the
studied genes and whatever the cell line considered, we
found a linear relation between the RIN and the
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(Table 2). The coefficients of determination (R
2) ranged
between 0.86 and 1.00. The mean slope value was 0.086
± 0.025 (95% CI 0.076–0.096). The relatively low
standard deviation observed indicates that all genes
had comparable degradation profiles. Obviously, the
lowest expression ratios were obtained for the most
degraded samples. The minimum ratio observed was
0.48 for the RPLP0 gene in the HCT116 sample with RIN
= 4.7 and it corresponded to a 2.08-fold difference
between the intact sample ratio and the measured
expression ratio. In other words, there was an error of
108% in the reported expression level of RPLP0 in this
sample. Similarly, the maximum errors observed for
samples with 5 ≤ RIN < 6, 6 ≤ RIN < 7, 7 ≤ R I N<8a n d
RIN ≥ 8 reached 104%, 92%, 75% and 47%, respectively.
Normalization of RNA degradation-related variations
using a RIN-based algorithm
To set up a normalizing factor that could compensate for
the loss of RNA integrity, we first determined the average
gene degradation profile based on the data we obtained
for 18S, ACTB, ATUB, B2M, GAPDH, HPRT, POLR2L,
PSMB6 and RPLP0 in the increasingly degraded HCT116,
BxPC-3 and A427 RNA samples (Figure 3). We then
modeled our data by linear regression analysis of the
mean measured ratios such that the average degradation
profile followed the relationship y = a × RIN + b, where
a = 0.08 and b = 0.19. Since each gene's transcription
level was expressed as an n-fold difference relative to the
RIN = 10 sample of the corresponding cell line, the
expected ratio for intact samples (RIN = 10) corre-
s p o n d e dt ot h el i n ey=1 .T h eR I N - n o r m a l i z e dr a t i o
(RRIN) could then be calculated as follow:
R Measured ratio Measured ratio y y RIN =+ × − (( ) / ) 1
To assess the validity of this normalization factor, we
applied our model to the quantification of EGFR, HER2
and HER3 expression in LS174T (colon adenocarci-
noma) and SKBr3 (breast carcinoma) samples displaying
variable RNA integrity (Table 3). For each measure, the
accuracy was greatly increased when using the corrective
factor. While pre-normalized data exhibited errors up to
100% in gene quantification, the maximum error after
normalization was below 25%. The mean error for the
normalized ratios was 8.4% ± 6.6 (95% CI 5.6–11.2).
Table 1: Genes examined
Gene symbol Gene name GenBank
accession no.
Primer sequences (5'Æ 3') Amplicon
size (bp)
qPCR
efficiency (%)
Control gene (assessment of RT-qPCR inhibitors)
CAB A. thaliana chlorophyll a/b-
binding protein
X56062 F: CCATTGCATTTGTTGAGCAC
R: CAATTCCTCGAGCTTCTTGG
119 100
Target genes – training set
18S 18S ribosomal RNA X03205 F: GGCGCCCCCTCGATGCTCTTAG
R:
GCTCGGGCCTGCTTTGAACACTCT
89 98
ACTB Beta-actin NM_001101 F: CTGTGGCATCCACGAAACTA
R: AGTACTTGCGCTCAGGAGGA
200 100
ATUB Alpha tubulin NM_006082 F: TTACCTCGACTCTTAGCTTGTCG
R: GGATGGAGATGCACTCACG
107 92
B2M Beta-2-microglobulin NM_004048 F: CACCCCCACTGAAAAAGATG
R:
ATATTAAAAAGCAAGCAAGCAGAA
167 93
GAPDH Glyceraldehyde-3-phosphate
dehydrogenase
NM_002046 F: TGCACCACCAACTGCTTAGC
R: GGCATGGACTGTGGTCATGAG
87 100
HPRT Hypoxanthine phosphoribosyl
transferase 1
NM_000194 F:
Forward and reverse primer sequences are indicated by "F" and "R", respectively.
TGATAGATCCATTCCTATGACTGTAGA
R: AAGACATTCTTTCCAGTTAAAGTTGAG12694POLR2LPolymerase RNA II polypeptide LNM_021128F: CAACAAGTGGGAGGCTTACCT
R: AGCTTCTCGATCAGGTCCAC13298PSMB6Proteasome subunit YNM_002798F: GATACCGGGAAGACCTGATG
R: AATGGCAAAGGACTGCCTTA11699RPLP0Ribosomal protein, large, P0NM_001002F: CACTGAGATCAGGGACATGTTG
R: CTTCACATGGGGCAATGG113100Target genes – validation setEGFREpidermal growth factor receptorNM_005228F:
CTGGATCCCAGAAGGTGAGA
R: GCCATCACGTAGGCTTCATC111100HER2v-erb-b2 erythroblastic leukemia viral oncogene homolog 2NM_004448F:
CTCCTCCTCGCCCTCTTG
R: AGCATGTCCAGGTGGGTCT10790HER3v-erb-b2 erythroblastic leukemia viral oncogene homolog 3NM_001982F:
GTGGACTCGAGCAACATTGA
R: CCGTACTGTCCGGAAGACAT14797Forward and reverse primer sequences are indicated by "F" and "R", respectively.
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in mRNA quantification of biopsy samples
To evaluate the accuracy of normalization to total RNA of
RT-qPCR data obtained from in vivo biopsies, we deter-
mined the RIN of 112RNA samples isolated from 56paired
normal/tumor rectal tissues (Figure 4). The majority
(73.2%) of samples were distributed in the 5 ≤ RIN < 6
and 6 ≤ RIN < 7 categories. One hundred and four RNA
sampleshadsufficientRNAconcentrationforRT,andcDNA
were obtained for these samples. Then, we compared the
relative expression of EGFR, HER2 and HER3 in these
samples (Figure 5 for EGFR) with and without the
application of our RIN-based normalization factor. The
mean fold-difference between non-normalized and RIN-
normalized valueswas 1.52± 0.17(95%CI1.47–1.55) and
ranged from 1.13 to 2.10. Moreover, our RIN-based
algorithm allowed the exposure of some differences in
gene expression levels among samples that could not have
been seen otherwise. For instance, without normalization,
sample 48 and 50 exhibited EGFR expression ratios of 4.59
Figure 1
Artificial degradation of HCT116 total RNA. Several aliquots of a single HCT116 total RNA preparation were degraded
at 70°C for different length of time and analyzed by the Agilent 2100 bioanalyzer. The resulting electrophoregrams and
RIN after 0, 30, 51, 75, 140 and 165 minutes of incubation are shown in panel A, B, C, D, E and F, respectively.
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Correlation between gene expression ratio and RIN in the HCT116 cell line. The expression measurements of nine
genes in increasingly degraded HCT116 samples are presented. The relationship between relative expression ratio and
RIN was modeled by linear regression analysis.
Table 2: Correlation between RIN and relative gene expression for 9 genes in the HCT116, BxPC-3 and A427 cell lines
Gene HCT116 BxPC-3 A427
Slope Intercept R
2 Slope Intercept R
2 Slope Intercept R
2
18S 0.09 0.16 0.98 0.14 -0.41 1.00 0.11 -0.16 0.94
ACTB 0.06 0.42 0.92 0.10 -0.03 0.94 0.06 0.41 0.99
ATUB 0.10 -0.01 0.96 0.14 -0.41 0.99 0.10 -0.01 0.95
B2M 0.10 -0.03 0.92 0.10 0.03 0.92 0.07 0.34 0.92
GAPDH 0.08 0.27 0.94 0.10 0.02 0.98 0.08 0.22 0.98
HPRT 0.09 0.08 0.94 0.10 0.05 0.86 0.08 0.16 0.96
POLR2L 0.06 0.4 0.98 0.06 0.43 0.92 0.04 0.60 0.97
PSMB6 0.07 0.35 0.97 0.09 0.14 0.99 0.05 0.53 0.99
RPLP0 0.09 0.09 0.94 0.11 -0.07 0.99 0.06 0.33 0.97
A regression analysis of the relationship between relative gene expression ratios and RIN was performed such that the expression ratio follows the
relationship y = a × RIN + b, a being the slope and b the intercept. The coefficients of determination (R
2) are also presented.
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that EGFR was expressed at similar levels in both samples.
After normalization of variations due to RNA degradation
using our corrective RIN-based algorithm, EGFR was more
strongly expressed in sample 48 (ratio = 9.60) than in
sample 50 (ratio = 6.91). Furthermore, variations in RNA
integrity may generate misleading differences in gene
expression measurements. Indeed, the non-normalized
ratios of sample 95 (ratio = 7.71) and sample 100 (ratio =
9.07) suggested that the former exhibited a lower
EGFR expression level, while the RIN-normalized ratios
led to the opposite conclusion. EGFR expression was
actually higher in sample 95 (ratio = 15.10) than in sample
100 (ratio = 11.51).
Discussion
Normalization of gene expression levels to total RNA
requires precise quantification of the RNA template.
Several methods exist for measuring RNA concentra-
tions, and we have previously discussed their respective
advantages and drawbacks [14]. In this study, we
determined total RNA concentration by measuring the
optical density at 260 nm with a TrayCell system
associated to a SAFAS UV mc2 spectrophotometer. This
system offers sensitivity down to 2 ng/μl and allows the
analysis of extremely small volumes (0.7–4 μl), which
has the advantage of avoiding dilution errors. Once the
sample concentration is accurately determined, the
simplest way to normalize gene expression using total
Figure 3
Determination of a RIN-based normalizing factor. (A) The measured expression ratios of 9 genes in HCT116, BxPC-3,
and A427 samples with decreasing RNA integrity allowed the determination of an average gene degradation profile that follows
the equation: relative expression ratio = 0.08 × RIN + 0.19. (B) A RIN-based normalizing factor was determined from the
deviation between the average gene degradation and the line y = 1, which corresponds to the expected ratio for intact samples
(RIN = 10).
Table 3: Normalization of EGFR, HER2 and HER3 expression according to the RIN
Cell line RIN EGFR HER2 HER3
Measured
ratio
(% error)
RIN-normalized
ratio
(% error)
Measured
ratio
(% error)
RIN-normalized
ratio
(% error)
Measured
ratio
(% error)
RIN-normalized
ratio
(% error)
LS174T 10.0 1.00 (0.0) - 1.00 (0.0) - 1.00 (0.0) -
8.0 0.75 (33.3) 0.91 (9.9) 0.76 (31.6) 0.93 (7.5) 0.83 (20.5) 1.01 (1.0)
7.1 0.63 (58.7) 0.84 (19.0) 0.74 (35.1) 0.99 (1.0) 0.63 (58.7) 0.84 (19.0)
6.6 0.60 (66.7) 0.85 (1.6) 0.63 (58.7) 0.89 (12.4) 0.62 (61.3) 0.87 (14.9)
5.4 0.50 (100.0) 0.81 (23.5) 0.60 (66.7) 0.98 (2.0) 0.55 (81.8) 0.89 (12.4)
SKBr3 10.0 1.00 (0.0) - 1.00 (0.0) - 1.00 (0.0) -
7.9 0.84 (19.0) 1.03 (3.0) 0.80 (25.0) 0.99 (1.0) 0.85 (17.6) 1.05 (5.0)
7.2 0.73 (37.0) 0.96 (4.2) 0.68 (47.0) 0.90 (11.1) 0.74 (35.1) 0.98 (2.0)
5.9 0.64 (56.2) 0.98 (2.0) 0.61 (63.9) 0.93 (7.5) 0.72 (38.9) 1.10 (10.0)
5.1 0.56 (78.6) 0.95 (5.2) 0.57(75.4) 0.96 (4.2) 0.63 (58.7) 1.07 (7.0)
EGFR, HER2 and HER3 gene transcription levels were assessed in LS174T and SKBr3 cell samples with decreasing RNA integrity and expressed as n-
fold difference relative to the intact (RIN = 10) sample. RIN-normalized ratios were calculated according to the following formula: RIN-normalized
ratio = Measured ratio + (Measured ratio × (1-(0.08 × RIN + 0.19))/(0.08 × RIN + 0.19)). The percent of error (% error) shows the accuracy of the
estimated (i.e. measured or normalized) ratio and was calculated as follow: % error = ((expected ratio – estimated ratio)/estimated ratio) × 100%.
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used for the RT reaction, all the more so that the cDNA
yield is dependent on template abundance [5,15].
Normalization to total RNA also requires assessment of
the presence of RT-qPCR inhibitors in samples [6,14].
These inhibitors, which may include reagents used
during RNA isolation, or co-purified biological compo-
nents [16,17], can reduce the efficiency of both RT and
PCR and generate errors in the quantification results. In
this study, we used an exogenous CAB mRNA control
[18,19] that was co-reverse-transcribed with each sample
RNA and then amplified by qPCR. Thus, any variation in
CAB expression level would reflect variations in the
efficiency of the RT and/or PCR steps. CAB showed a 1.5-
fold variation range in our cell line cDNA samples,
which is comparable to or even narrower than previously
reported values for similar exogenous controls [6,19,20].
We conclude that in our samples and under our
optimized RT-qPCR conditions, there was only a
negligible effect of inhibitors on the RT and PCR
efficiencies.
Bustin et al. [7] recommended normalization to accu-
rately quantitated total RNA as the least unreliable
method, and Tricarico et al. [6] validated it for breast
biopsies [6]. However, little was known at that time
about the accuracy of this approach when using
degraded RNA samples. In this study, we assessed the
effect of RNA degradation on the relative gene expression
level measured by RT-qPCR in 3 different models,
namely colorectal carcinoma (HCT116), pancreatic
adenocarcinoma (BxPC-3) and lung adenocarcinoma
(A427) cell lines. Different methods to degrade RNA
have been described in the literature, including the use of
RNase treatment [11], UV radiation [11], or thermal
hydrolysis [21]. While these procedures are artificial and
may differ from the natural degradation that occurs
during sample handling, they allow producing a collec-
tion of RNA samples that are representative of all
possible degrees of RNA degradation. Using thermal
hydrolysis, we degraded total RNA isolated from
HCT116, BxPC-3 and A427 cell lines. We thus obtained
samples with decreasing integrity, with RIN values
ranging from 10 (intact RNA) to 4.7 (highly degraded
RNA), which corresponded to the range allowing reliable
RT-qPCR quantification analysis [11]. Then, we mea-
sured the expression of 18S, ACTB, ATUB, B2M, GAPDH,
HPRT, POLR2L, PSMB6 and RPLP0, a group of genes that
covers a wide expression range. Since all samples from a
given cell line had the same transcriptome, the decrease
in the measured gene expression ratios accurately
reflected the effect of RNA degradation. Our data
demonstrate that there is a linear correlation between
the relative expression ratio of a gene and the RIN: the
lower the RIN, the higher the decrease in the measured
expression level. One should keep in mind that these
results may be specific to the protocol used in this study.
We have carefully designed our protocol in order to
reduce the effects of RNA degradation and maximize the
yield of the RT reaction. Specifically, we preferred
random hexamers over oligo(dT) or specific primers,
which are not appropriate for fragmented RNA [8], and
Figure 4
RIN value frequency distribution for RNA isolated
from 112 rectal biopsies. Dark and light bars correspond
to tumor and normal samples, respectively. Figure 5
Application of the RIN-based normalization factor
for EGFR quantification in rectal biopsy samples.T h e
relative expression ratio corresponds to EGFR expression
level, expressed as an n-fold difference relative to the sample
with the lowest EGFR expression. Dark and light gray bars
correspond to non-normalized and RIN-normalized relative
expression ratios, respectively.
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asshort ampliconshavebeenshowntobe lessdependent
onRNAintegrity[10].Fleigeetal.[11]havealreadytested
the effect of artificial RNA degradation on gene expres-
sion for a limited number of genes (18S, 28S, ACTB and
IL-1b) in a large panel of human tissue-derived RNAs.
Similarly to our results, they found a linear correlation
between gene expression and RIN. However, in their
study, this was not true for all tissue types. This may be
imputed to differences between our experimental proto-
cols. Specifically, they performed one-step RT-qPCR
assays with specific primers, and chose longer PCR
products (i.e., 198–338 pb). Tissues definitely show
different sensitivity to RNA degradation, but for a
givengene that is similarly expressed in two different
tissues, the quantification of its expression using an
optimized RT-qPCR protocol should be influenced only
by the sample's degradation level (i.e. its RIN value), and
not by the tissue type.
In our experiment, the most degraded samples exhibited up
to 2-fold decrease in gene expression levels. This demon-
strates that, for samples with RIN values down to 4.7,
variations in RNA integrity may generate an error of
approximately 100% in gene quantification. To address
this issue, we asked whether it was possible to determine a
RIN-based algorithm that normalizes the loss of RNA
integrity in gene quantification. This implies the determina-
tionofthegeneofinterest'sdegradationprofile.Since1)itis
hardly conceivable to model all possible degradation
profiles in the short term and 2) the 9 training genes
analyzed in this study showed similar degradation profiles,
wechose todetermine an average degradation profilebased
on the data we obtained for these genes incolon, pancreatic
and lung cancer cells. Then, using this consensus profile, we
calculated a normalizing factor that adjusted the RIN-
dependent quantitative measure to the expected value for
intact samples.
Toassessthevalidityofthiscorrectivealgorithm,weapplied
the proposed normalization method to the quantification
of EGFR, HER2 and HER3 in samples with decreasing RNA
integrity obtained from two model-independent cancer cell
lines (LS174T, colon; SKBr3, breast). Our results demon-
strate that the developed approach greatly reduces RNA
degradation-related variations for all genes in each sample.
The use of the RIN-corrective algorithm lowered the
maximum error in quantification from 100% to less than
25%, and an average error of less than 10% was obtained.
Such accuracy is desirable, since minimal changes in gene
expression levels can have important functional [22] or
clinical [23] consequences.
For studies involving human biopsies, analysis of
samples with variable RNA integrity is unavoidable as
RNA is usually degraded during sample handling.
Therefore, normalization of variations due to RNA
degradation is of critical importance. In this study, we
assessed the degradation level of 112 RNA extracted from
56 matching normal and tumor rectal biopsies pairs.
Nearly 75% of samples showed RIN values comprised
between 5 and 7 and our experiment with gradually
degraded cell lines demonstrated that samples within
this range of RIN could exhibit important errors in gene
expression measurements. To assess the benefit of our
RIN-based corrective algorithm, we measured the expres-
sion of EGFR, HER2 and HER3 in 104 of the 112 RNAs
derived from biopsies and compared non-normalized
and RIN-normalized ratios. Our data indicate that,
without normalization, differences in sample RNA
integrity could generate artificial up- or down-regula-
tions that could lead to misleading interpretation of the
results. Although our model will not fit perfectly each
gene due to possible differences in degradation profiles,
it will significantly reduce unspecific variations. There-
fore, we recommend the use of our RIN-based corrective
algorithm when normalizing gene expression measure-
ments to accurately quantitated RNA. However, this
requires the use of our RT protocol and the design of
short PCR products (< 200 pb). To make this normal-
ization process more user-friendly, we plan to develop a
software program that normalizes target gene expression
measurements according to the RIN value in an
automatic manner.
Conclusion
The precision and accuracy of gene expression measure-
ments with RT-qPCR depend on the method used to
normalize the data. In this study, we demonstrate that
the use of total RNA for RT-qPCR normalization is
limited when small differences in gene expression need
to be detected. To achieve higher accuracy in RT-qPCR
measurements, we improved this method by introducing
a RIN-based corrective algorithm. This strategy should
correct variations related to RNA degradation and allow
accurate gene expression quantitation.
Methods
Patients' tissues and cell line
The human cancer cell lines HCT116, BxPC-3, A427,
SKBr3 and LS174T were purchased from the American
Type Culture Collection and cultured under standard
conditions. Cells were harvested at 50% confluence,
washed with phosphate buffered saline, and subse-
quently used for RNA extraction.
Fifty-six rectal cancer patients were included in this study
between January 2006 and February 2008. For all
patients, pre-therapeutic biopsies from paired normal/
BMC Molecular Biology 2009, 10:31 http://www.biomedcentral.com/1471-2199/10/31
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Biopsies were frozen at -80°C within 45 minutes and
stored under this condition until extraction. The proto-
col was approved by the CPP of Saint-Eloi Hospital
(Montpellier, France), a French Ethic committee for the
protection of patients involved in biomedical research.
RNA Isolation and Characterization
Total RNA was isolated using the RNeasy Mini Kit
(Qiagen, Courtaboeuf, France) following the manufac-
turer's instructions. The extraction included a digestion
step with DNase I to prevent subsequent amplification of
genomic DNA. Total RNA concentration was determined
by measuring the absorbance at 260 nm (A260)w i t ht h e
SAFAS UV mc2 spectrophotometer (Safas, Monaco,
Monaco), using a TrayCell system (Hellma, Paris,
France). Total RNA purity was verified by determining
the A260/A280 ratio. RNA integrity was assessed by
microcapillary electrophoresis with the RNA 6000
Nano LabChip kit (Agilent Biotechnologies, Massy,
France) and the Agilent 2100 bioanalyzer (Agilent
Biotechnologies), which assigns a RIN to each RNA
electropherogram. This number ranges from 1 (comple-
tely degraded RNA sample) to 10 (intact RNA sample).
Reverse transcription
For each sample, a 13-μl mix containing 1 μgt o t a lR N A ,
150 ng of random hexamers (Promega, Charbonnieres,
France), 1 μl of a 10 mM dNTP Mix (Invitrogen, Cergy
Pontoise, France), and 0,3 pg of an exogenous plant
mRNA spike (A. thaliana chlorophyll a/b-binding pro-
t e i n ,C A B )( S t r a t a g e n e ,A m s t e r d a m ,T h eN e t h e r l a n d s )
was heated at 65°C for 5 minutes. After cooling on ice, a
7 μl-reaction mix containing 1 μl of SuperScript™ III
Reverse Transcriptase (200 U/μl) (Invitrogen), 4 μlo f5 ×
First-Strand Buffer (Invitrogen), 1 μlo f0 . 1MD T T
(Invitrogen), and 1 μlo fS U P E R a s e .I n ™ (20 U/μl)
(Ambion, Huntingdon, UK) was added. Then reverse
transcription was performed in an Eppendorf
® Master-
cycler
®
(Eppendorf, Le Pecq, France) with an initial
priming step at 25°C for 5 minutes, followed by cDNA
synthesis at 50°C for 60 minutes. A final inactivation
step at 70°C for 15 minutes completed the reaction.
Quantitative real-time RT-PCR analysis
We developed quantitative SYBR green PCR assays for
the 12 genes involved in this study and the spiked plant
mRNA control (Table 1). Real-time PCR amplification
was performed in a Rotor-Gene™ 6000 (Labgene,
Archamps, France) using the ABsolute™ Blue QPCR
SYBR
® Green Mix (ABgene, Courtaboeuf, France). PCR
amplification were carried out in a 20-μl volume with
the following cycling conditions: an enzyme activation
step at 95°C for 15 minutes, followed by 40 cycles
consisting of 15 seconds of denaturation at 95°C, 30
seconds of annealing at 58–64°C depending on primers,
and 30 seconds of elongation at 72°C. The specificity of
the amplified products was verified by melting curve
analysis and agarose gel electrophoresis. For each qPCR
run, a standard curve was generated using serial dilutions
of a standard cDNA. Amplification efficiencies (E) were
calculated from the slope of the standard curves
a c c o r d i n gt ot h ee q u a t i o n :E=1 0[ - 1 / slope], and they
ranged from 90% to 100%. To exclude between-run
variations, all cDNA samples were tested in duplicate in
the same analytical run along with a calibrator. A value
of 1 was attributed to the calibrator and all gene
expression levels were expressed as an n-fold difference
relative to the calibrator, according to the relative
standard curve method [24].
Statistical analysis
All statistical analyses were performed with the STATA
10.0 software (StataCorp, College Station, TX).
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